Your browser doesn't support javascript.
loading
A new staging system for postoperative prognostication in pancreatic ductal adenocarcinoma.
Liang, Yuexiang; Cui, Jingli; Ding, Fanghui; Zou, Yiping; Guo, Hanhan; Man, Quan; Chang, Shaofei; Gao, Song; Hao, Jihui.
Afiliação
  • Liang Y; Department of Pancreatic Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center For Cancer, Tianjin 30060, China.
  • Cui J; Department of Gastrointestinal Oncology Surgery, Center of Cancer Prevention and Therapy, the First Affiliated Hospital of Hainan Medical University, Haikou 570102, China.
  • Ding F; Department of Pancreatic Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center For Cancer, Tianjin 30060, China.
  • Zou Y; Department of General Surgery, Weifang People's Hospital, Weifang 261044, China.
  • Guo H; Department of General Surgery, the First Hospital of Lanzhou University, Lanzhou 730013, China.
  • Man Q; Department of Pancreatic Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center For Cancer, Tianjin 30060, China.
  • Chang S; Department of Gastrointestinal Oncology Surgery, Center of Cancer Prevention and Therapy, the First Affiliated Hospital of Hainan Medical University, Haikou 570102, China.
  • Gao S; Department of Pancreatic Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center For Cancer, Tianjin 30060, China.
  • Hao J; Department of Pancreatic Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center For Cancer, Tianjin 30060, China.
iScience ; 26(9): 107589, 2023 Sep 15.
Article em En | MEDLINE | ID: mdl-37664604
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article